Production in Escherichia coli of recombinant COVID-19 spike protein fragments fused to CRM197
- 20 April 2021
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 558, 79-85
- https://doi.org/10.1016/j.bbrc.2021.04.056
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Stabilization of the Escherichia coli DNA polymerase III ε subunit by the θ subunit favors in vivo assembly of the Pol III catalytic coreArchives of Biochemistry and Biophysics, 2012
- Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197Proceedings of the National Academy of Sciences of the United States of America, 2012
- Overexpression and purification of the recombinant diphtheria toxin variant CRM197 in Escherichia coliJournal of Biotechnology, 2011
- In-gel digestion for mass spectrometric characterization of proteins and proteomesNature Protocols, 2006
- Antigen Processing of the Heptavalent Pneumococcal Conjugate Vaccine Carrier Protein CRM197Differs Depending on the Serotype of the Attached PolysaccharideInfection and Immunity, 2003
- Immune response to diphtheria toxin and to different CNBr fragments: Evidence for different B and T cell reactivitiesEuropean Journal of Immunology, 1986
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- An immunological study of the diphtheria toxin moleculeImmunochemistry, 1972
- CRYSTALLINE DESOXYRIBONUCLEASEThe Journal of general physiology, 1950